Proportions of Proinflammatory Monocytes Are Important Predictors of Mortality Risk in Hemodialysis Patients
Table 2
The results of association analysis for CD16+ monocytes.
Variables
CD16+ monocyte level
value
6.5~15.6
>15.6, ≤18.6
>18.6, ≤21.5
>21.5, ≤29.2
n
34
34
34
33
n (%)
n (%)
n (%)
n (%)
Sex
Female
15 (44.12%)
14 (41.18%)
15 (44.12%)
18(54.55%)
0.374
Male
19 (55.88%)
20 (58.82%)
19 (55.88%)
15(45.45%)
DM
No
20 (58.82%)
18 (52.94%)
16 (47.06%)
13(39.39%)
0.083
Yes
14 (41.18%)
16 (47.06%)
18 (52.94%)
20(60.61%)
Hypertension
0.806
No
8 (23.53%)
11 (32.35%)
11 (32.35%)
8(24.24%)
Yes
26 (76.47%)
23 (67.65%)
23 (67.65%)
25(75.76%)
Preexisting CAD or CeVD
No
22 (64.71%)
20 (58.82%)
13 (40.63%)
7(21.21%)
<0.0001
Yes
12 (35.29%)
14 (41.18%)
19 (59.38%)
26(78.79%)
HD vintage (year)
0–3
7 (20.59%)
4 (11.76%)
6 (17.65%)
3(9.09%)
0.849
>3, ≤5
8 (23.53%)
10 (29.41%)
8 (23.53%)
11(33.33%)
>5, ≤8
6 (17.65%)
11 (32.35%)
14 (41.18%)
6(18.18%)
>8
13 (38.24%)
9 (26.47%)
6 (17.65%)
13(39.39%)
Mean ± SD
Mean ± SD
Mean ± SD
Mean ± SD
CD16+ monocytes, %
12.77 ± 2.32
16.96 ± 0.87
20.28 ± 0.87
24.77 ± 2.07
—
HD vintage, year
7.99 ± 5.74
6.8 ± 3.81
6.29 ± 3.82
6.89 ± 3.59
0.753
Age, year
56.03 ± 12.03
59.91 ± 11.35
61.59 ± 13.15
63.45 ± 10.67
0.004
BMI, kg/m2
23.1 ± 3.38
23.31 ± 3.64
23.1 ± 3.27
25.03 ± 3.88
0.238
WBC, 103/mm3
7.08 ± 2.12
6.28 ± 1.43
6.53 ± 1.58
6.32 ± 1.35
0.245
Monocyte, 103/μl
5.71 ± 1.77
5.89 ± 1.58
6.27 ± 1.74
6.06 ± 1.47
0.192
AbsoMono, cells/μl
413.94 ± 214.01
366.77 ± 117.41
408.65 ± 149.62
380.39 ± 120.19
0.961
HsCRP, mg/l
2.57 ± 1.42
2.42 ± 1.46
2.49 ± 1.41
2.96 ± 1.34
0.367
Hb, g/dl
11.47 ± 1.59
11.39 ± 1.31
11.15 ± 1.57
10.97 ± 1.27
0.135
PLT, 104/cm3
143.21 ± 90.39
124.96 ± 82.61
163.69 ± 88.49
153.32 ± 89.62
0.311
FBS, mg/dl
110.85 ± 42.25
111.86 ± 43.94
126.56 ± 59.31
114.76 ± 45.17
0.732
HbA1c, %
6.38 ± 1.72
5.96 ± 1.29
6.29 ± 1.33
6.59 ± 1.71
0.198
Albumin, g/dl
4.24 ± 0.22
4.43 ± 1.45
4.18 ± 0.32
4.1 ± 0.29
0.163
Ferritin, μg/dl
657.41 ± 256.8
594.68 ± 271.22
745.94 ± 326.2
717.58 ± 288.81
0.041
TG, mg/dl
144.56 ± 107.83
132.05 ± 73.32
154.29 ± 105.66
141.42 ± 83.4
0.782
HDL, mg/dl
47.18 ± 17.99
48.82 ± 17.11
48.03 ± 19.79
43.48 ± 14.52
0.877
Cholesterol, mg/dl
168.5 ± 37.08
165.7 ± 37.16
161.24 ± 37.81
164.12 ± 41.12
0.767
rTG
0.86 ± 0.6
0.82 ± 0.39
0.9 ± 0.52
0.88 ± 0.49
0.805
rHDL
0.29 ± 0.11
0.31 ± 0.12
0.3 ± 0.11
0.27 ± 0.09
0.757
cHDL, mg/dl
121.32 ± 36.73
116.58 ± 37.82
113.21 ± 34.76
120.64 ± 38.17
0.689
BUN, mg/dl
67.6 ± 14.69
67.32 ± 12.52
66.88 ± 12.84
65.98 ± 15.42
0.59
Cr, mg/dl
10.84 ± 2
10.66 ± 2.24
10.72 ± 2.3
10.07 ± 2.12
0.149
UA, mg/dl
7.56 ± 1.49
7.85 ± 1.35
7.65 ± 1.25
7.17 ± 1.93
0.622
Ca, mg/dl
13.32 ± 22.21
9.43 ± 0.39
9.26 ± 0.65
9.38 ± 0.79
0.225
P, mg/dl
4.65 ± 1.46
4.75 ± 1.35
4.41 ± 1.2
4.76 ± 1.4
0.55
SBP, mmHg
134.91 ± 22.34
138.85 ± 19.65
135.79 ± 15.02
140.88 ± 25.02
0.446
DBP, mmHg
78 ± 10.53
76.38 ± 10.38
76.15 ± 8.33
75.79 ± 9.69
0.479
Note: the abbreviations are the same as those denoted in Table 1. value of Spearman’s association test using the raw data value of CD16+ monocytes and observed variables.
